Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysplastic nevi and malignant melanoma.

W A Crutcher1, P J Cohen

  • 1Children's Hospital of San Franscisco, California.

American Family Physician
|August 1, 1990
PubMed
Summary

Early detection of melanoma is crucial due to rising incidence and younger age trends. Routine screening for melanoma and dysplastic nevi is vital for timely intervention and risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A shooting on Capitol Hill: "The Ruby Satellite System," mental illness, and failure of the American legal system.

Kennedy Institute of Ethics journal·2002
Same author

Bedside rationing of health care.

JAMA·2001
Same author

Poor Hippocrates.

Anesthesiology·2000
Same author

Availability of organ donors.

The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha·1999
Same author

Ethics for non-emergencies.

Anesthesiology·1999
Same author

Plus ça change.

Anesthesiology·1999

Area of Science:

  • Dermatology
  • Oncology
  • Public Health

Background:

  • Melanoma incidence is increasing, with a concerning trend towards younger patients.
  • Early intervention is the most effective treatment for melanoma.
  • Dysplastic nevi are a significant risk factor for melanoma development.

Purpose of the Study:

  • To emphasize the importance of routine screening for melanoma and dysplastic nevi.
  • To highlight the increased melanoma risk associated with dysplastic nevi.
  • To advocate for increased public and physician awareness regarding melanoma risk factors.

Main Methods:

  • Review of current literature on melanoma incidence and risk factors.
  • Estimation of dysplastic nevus prevalence and associated melanoma risk.
  • Identification of key risk factors for melanoma.

Main Results:

  • Dysplastic nevus prevalence is estimated at 2-5%.
  • Patients with dysplastic nevi have a 6% lifetime melanoma risk, potentially exceeding 50% in high-risk individuals.
  • Risk factors include dysplastic nevi, freckling, sunburn tendency, and numerous common nevi.

Conclusions:

  • Routine screening examinations are essential for early melanoma detection.
  • Patients with dysplastic nevi require periodic follow-up and may benefit from screening family members.
  • Public education and heightened physician awareness are critical for reducing melanoma mortality.

Related Experiment Videos